Aldeyra Therapeutics (ALDX) Other Accumulated Expenses (2014 - 2015)
Aldeyra Therapeutics' (ALDX) quarterly Other Accumulated Expenses came in at $48657.0 in Q4 2015, little changed YoY from $48839.0 in Q4 2014, and down 60.33% on a QoQ basis from $122664.0 in Q3 2015.
Aldeyra Therapeutics (ALDX) Other Accumulated Expenses (2014 - 2015) Analysis & Trends
Aldeyra Therapeutics (ALDX) has 2 years of Other Accumulated Expenses data on file, last reported at $48657.0 in Q4 2015.
- Quarterly Other Accumulated Expenses changed 0.37% year-over-year to $48657.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $48657.0 (changed 0.37% YoY) and the FY2015 annual result came in at $48657.0, changed 0.37% from the prior year.
- Other Accumulated Expenses fell to $48657.0 in Q4 2015, from $122664.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $122664.0 in Q3 2015 to a low of $48657.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Aldeyra Therapeutics | 90.18 Mn | 90.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 48,657.00 |
| Sep 30, 2015 | 122,664.00 |
| Dec 31, 2014 | 48,839.00 |